Santhera Pharmaceuticals Holding AG (SANN) — Capital Reinvestment Ratio
Santhera Pharmaceuticals Holding AG (SANN) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow (CHF62.63 Million) in capital expenditures (CHF90.00K). See Santhera Pharmaceuticals Holding AG (SANN) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Santhera Pharmaceuticals Holding AG Capital Reinvestment Ratio (2019–2023)
This chart tracks Santhera Pharmaceuticals Holding AG's Capital Reinvestment Ratio across 2 annual periods. Check SANN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Santhera Pharmaceuticals Holding AG (2019–2023)
Year-by-year Capital Reinvestment Ratio for Santhera Pharmaceuticals Holding AG from 2019 to 2023. For live market cap and broader valuation context, see Santhera Pharmaceuticals Holding AG market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.50x | CHF47.27 Million | CHF23.74 Million | ▲ +469.2% |
| 2019 | 0.09x | CHF2.60 Million | CHF229.00K | — |